A 48-year-old man with confirmed Meniere disease (low-frequency SNHL, episodic vertigo, tinnitus, aural fullness) has had 3–4 attacks per month over the past 6 months despite salt restriction and fluid management. He is now seeking long-term prophylactic therapy to reduce attack frequency. Which drug is the preferred first-line prophylactic agent?